Matthew Kaplan
Stock Analyst at Ladenburg Thalmann
(2.74)
# 1,894
Out of 4,893 analysts
26
Total ratings
58.33%
Success rate
17.23%
Average return
Main Sectors:
Stocks Rated by Matthew Kaplan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UTHR United Therapeutics | Maintains: Buy | $319 → $344 | $300.56 | +14.45% | 9 | Oct 31, 2024 | |
| URGN UroGen Pharma | Maintains: Buy | $48 → $54 | $13.81 | +287.40% | 1 | Jun 14, 2024 | |
| TGTX TG Therapeutics | Maintains: Buy | $39 → $40 | $37.92 | +5.49% | 3 | May 2, 2024 | |
| LQDA Liquidia | Maintains: Buy | $15 → $30 | $13.48 | +122.55% | 2 | Dec 21, 2023 | |
| ARDX Ardelyx | Maintains: Buy | $7.5 → $8.5 | $4.60 | +84.78% | 4 | Aug 3, 2023 | |
| AVDL Avadel Pharmaceuticals | Maintains: Buy | $15 → $16 | $9.55 | +67.54% | 1 | May 2, 2023 | |
| KPRX Kiora Pharmaceuticals | Reiterates: Buy | $1,071 | $2.97 | +35,960.61% | 2 | Feb 8, 2023 | |
| XAIR Beyond Air | Maintains: Buy | $17 → $23 | $0.21 | +10,852.38% | 1 | Jun 29, 2022 | |
| LPCN Lipocine | Upgrades: Buy | $51 | $3.21 | +1,490.42% | 1 | Dec 10, 2020 | |
| COGT Cogent Biosciences | Initiates: Buy | $16 | $10.40 | +53.85% | 1 | Oct 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $45 | $3.22 | +1,297.52% | 1 | Jan 22, 2020 |
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $319 → $344
Current: $300.56
Upside: +14.45%
UroGen Pharma
Jun 14, 2024
Maintains: Buy
Price Target: $48 → $54
Current: $13.81
Upside: +287.40%
TG Therapeutics
May 2, 2024
Maintains: Buy
Price Target: $39 → $40
Current: $37.92
Upside: +5.49%
Liquidia
Dec 21, 2023
Maintains: Buy
Price Target: $15 → $30
Current: $13.48
Upside: +122.55%
Ardelyx
Aug 3, 2023
Maintains: Buy
Price Target: $7.5 → $8.5
Current: $4.60
Upside: +84.78%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Buy
Price Target: $15 → $16
Current: $9.55
Upside: +67.54%
Kiora Pharmaceuticals
Feb 8, 2023
Reiterates: Buy
Price Target: $1,071
Current: $2.97
Upside: +35,960.61%
Beyond Air
Jun 29, 2022
Maintains: Buy
Price Target: $17 → $23
Current: $0.21
Upside: +10,852.38%
Lipocine
Dec 10, 2020
Upgrades: Buy
Price Target: $51
Current: $3.21
Upside: +1,490.42%
Cogent Biosciences
Oct 14, 2020
Initiates: Buy
Price Target: $16
Current: $10.40
Upside: +53.85%
Jan 22, 2020
Initiates: Buy
Price Target: $45
Current: $3.22
Upside: +1,297.52%